Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720980 · ClinicalTrials.gov registry record
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 6
- Enrollment target
NCT00720980: Completed study, sponsored by Henry Ford Health System.
NCT00720980 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00720980 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or disseminated form can occur. The etiology of granuloma annulare is unknown, however, multiple inciting factors have been proposed. The purpose of the investigators is to review the outcomes of treatment of granuloma annulare (GA) resistant to standard regimens that resolved after a 3-months treatment course of monthly rifampin, ofloxacin, and minocycline (ROM) therapy, successfully used to treat paucibacillary leprosy, a disease with clinical and histopathologic similarity to GA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-07 |
What the finished NCT00720980 record still lists
NCT00720980 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00720980 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00720980 about?
NCT00720980 is a clinical study titled "Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy". Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or ...
What is the current status of trial NCT00720980?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2008-05. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00720980?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia